Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Bela Kiss"'
Autor:
Denisa-Mădălina Zălar, Cristina Pop, Elena Buzdugan, Bela Kiss, Maria-Georgia Ştefan, Steliana Ghibu, Doiniţa Crişan, Alexandra Buruiană-Simic, Adriana Grozav, Ileana Monica Borda, Cristina Ionela Mogoșan
Publikováno v:
Antioxidants, Vol 11, Iss 2, p 230 (2022)
Inflammation and hyperlipidemia play an essential role in the pathophysiology of endothelial dysfunction as well as atherosclerotic plaque formation, progression and rupture. Colchicine has direct anti-inflammatory effects by inhibiting multiple infl
Externí odkaz:
https://doaj.org/article/f43b669fd9cd4a01b05b06ea061afa65
Autor:
Ionel Fizesan, Cristian Iacovita, Anca Pop, Bela Kiss, Roxana Dudric, Rares Stiufiuc, Constantin Mihai Lucaciu, Felicia Loghin
Publikováno v:
Pharmaceutics, Vol 13, Iss 12, p 2148 (2021)
The clinical translation of magnetic hyperthermia (MH) needs magnetic nanoparticles (MNPs) with enhanced heating properties and good biocompatibility. Many studies were devoted lately to the increase in the heating power of iron oxide MNPs by doping
Externí odkaz:
https://doaj.org/article/3a63cb44b58f4d64afd398998d1c8f52
Autor:
Marius Emil Rusu, Carmen Georgiu, Anca Pop, Andrei Mocan, Bela Kiss, Oliviu Vostinaru, Ionel Fizesan, Maria-Georgia Stefan, Ana-Maria Gheldiu, Letitia Mates, Rebeca Moldovan, Dana Maria Muntean, Felicia Loghin, Laurian Vlase, Daniela-Saveta Popa
Publikováno v:
Antioxidants, Vol 9, Iss 5, p 424 (2020)
Antioxidant dietary intervention is considered a potential strategy in delaying age-related dysfunctions. In this study of 56 days, we assessed the antioxidant effects of walnut kernel (WK) and walnut septum extract (WSE) in a D-galactose (D-gal)-ind
Externí odkaz:
https://doaj.org/article/693a20670f224e3c8fe4db3c5f9ea086
Autor:
Balázs Lendvai, Andrew G. Foley, Viktor Román, Nika Adham, Bence Farkas, Bela Kiss, Lynsey Hanratty
Publikováno v:
Psychopharmacology
Rationale Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by deficits in social communication and interaction and restricted, repetitive behaviors. The unmet medical need in ASD is considerable since there is no approve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcd3909bbf0f8c99a2db16da4c526b88
http://europepmc.org/articles/PMC8373751
http://europepmc.org/articles/PMC8373751
Autor:
Bence Farkas, Pálma Diószegi, Balázs Lendvai, Gabriella Nyitrai, András Czurkó, Ottilia Balázs, Bela Kiss
Publikováno v:
Journal of Psychopharmacology. 35:303-310
Background: Cariprazine is a dopamine D3-preferring D3/D2 receptor partial agonist compound recently introduced to treat schizophrenia and bipolar disorder. Although cariprazine is clinically classified as a low-somnolence drug, to date no detailed p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a02b2fe918c90b18622f8822d5f7ee
https://doi.org/10.1177/0269881120981378
https://doi.org/10.1177/0269881120981378
Autor:
Chidibere M Iro, Mostafa El Mansari, Nika Adham, Bence Farkas, Pierre Blier, Mohammad Ali Ebrahimzadeh, Bela Kiss, Rami Hamati
Publikováno v:
Journal of Psychopharmacology. 34:1143-1154
Background: Cariprazine, the novel dopamine (DA) D3-preferring D3/D2 and serotonin (5-HT)1A receptor partial agonist, has activity as an adjunctive therapy in major depressive disorder (MDD). Aims: This study aims to investigate the effects of chroni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb47dcf3042e31f2b0c72680b7d5b23c
https://doi.org/10.1177/0269881120936891
https://doi.org/10.1177/0269881120936891
Autor:
Nika Adham, Balázs Lendvai, Zoltan Gerevich, Christoph Kulisch, Clement E. Lemercier, Bela Kiss, Maria A. Meier
Publikováno v:
British Journal of Pharmacology
Background and purpose Gamma oscillations are fast rhythmic fluctuations of neuronal network activity ranging from 30 to 90 Hz that establish a precise temporal background for cognitive processes such as perception, sensory processing, learning, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bdb9055217881817e5e83de3f4c4d1c
https://doi.org/10.1111/bph.14923
https://doi.org/10.1111/bph.14923
Autor:
Ottilia Balázs, Károly Fazekas, Balázs Lendvai, Zsolt Némethy, Katalin Saghy, Istvan Gyertyan, Bence Farkas, Etelka Bolf-Terjéki, Bela Kiss, Dalma Kurkó, Norbert Antal Kirschner, István Laszlovszky
Publikováno v:
Drug Design, Development and Therapy. 13:3229-3248
Introduction Cariprazine, a dopamine D3-preferring D3/D2 receptor partial agonist and serotonin 5-HT1A receptor partial agonist, has two major human metabolites, desmethyl-cariprazine (DCAR) and didesmethyl-cariprazine (DDCAR). The metabolite pharmac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8aea3c4b8b6fbbb53c87fd7c077f53f
https://doi.org/10.2147/dddt.s188760
https://doi.org/10.2147/dddt.s188760
Autor:
Istvan Laszlovszky, András Visegrády, Balázs Krámos, Viktor Román, Balázs Lendvai, Bela Kiss, Amrita Ágnes Bobok, György Lévay
Publikováno v:
Biomolecules
Biomolecules, Vol 11, Iss 104, p 104 (2021)
Biomolecules, Vol 11, Iss 104, p 104 (2021)
Dopamine (DA), as one of the major neurotransmitters in the central nervous system (CNS) and periphery, exerts its actions through five types of receptors which belong to two major subfamilies such as D1-like (i.e., D1 and D5 receptors) and D2-like (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de84aeafafed70255736933fb94c31f7
https://pubmed.ncbi.nlm.nih.gov/33466844
https://pubmed.ncbi.nlm.nih.gov/33466844
Autor:
Bela Kiss, Charles R. Ashby, Renaud Rovera, Bence Farkas, Nika Adham, Sarah Delcourte, Nasser Haddjeri
Publikováno v:
CNS Neuroscience & Therapeutics
Aim Cariprazine, a dopamine D3 -preferring D3 /D2 receptor partial agonist, is FDA approved for the treatment of schizophrenia and acute manic or mixed episodes of bipolar disorder. This study used in vivo electrophysiological techniques in anestheti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::732065b48bdbb8724379f20dc122438a
http://europepmc.org/articles/PMC6282959
http://europepmc.org/articles/PMC6282959